Antitumor progression potential of morusin suppressing STAT3 and NFκB in human hepatoma SK-Hep1 cells

Toxicology Letters

Volumn 232, Issue 2, 2015, Pages 490-498

  Lin, Wea Lung ^a   Lai, Deng Yu ^b   Lee, Yean Jang ^b   Chen, Nai Fang ^c   Tseng, Tsui Hwa ^a,c  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hepatoma; Morusin; NF B; SK Hep 1 cells; STAT3; Tumor progression

Indexed keywords

ALPHA2 INTEGRIN; ALPHA6 INTEGRIN; ANTINEOPLASTIC AGENT; BETA1 INTEGRIN; FLAVONOID; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MORUSIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; STAT3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ADHESION; CELL INVASION; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; EXTRACELLULAR MATRIX; GENE REPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LIVER CELL CARCINOMA; LUNG; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; GENETICS; METABOLISM; NUDE MOUSE; TUMOR CELL LINE; TUMOR INVASION;

MORACEAE; MORUS (PLANT); MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; FLAVONOIDS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NF-KAPPA B; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84919798187     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.11.031     Document Type: Article

References (25)

1. Bollrath J., Greten F.R. IKK/NF-κB and STAT3 pathways: central signaling hubs in inflammation-mediated tumor promotion and metastasis. EMBO Rep. 2009, 10:1314-1319.
2. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2:563-572.
3. Engbring J., Kleinman H.K. The basement membrane matrix in malignancy. J. Pathol. 2003, 200:465-470.
4. Fotsis T., Pepper M.S., Aktas E., Breit S., Rasku S., Adlercreutz H., Wähälä K., Montesano R., Schweigerer L. Flavonoid, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 1997, 57:2916-2921.
5. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 2003, 3:362-374.
6. Grivennikov S., Karin M. Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010, 21:11-19.
7. Guo W., Giancotti F.G. Integrin signaling during tumor progression. Nat. Rev. Mol. Cell Biol. 2004, 5:816-826.
8. Haftchenary S., Avadisian M., Gunning P.T. Inhibiting aberrant STAT3 function with molecular therapeutics: a progress report. Anti-Cancer Drugs 2011, 22:115-127.
9. He G., Karin M. NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Res. 2011, 21:159-168.
10. Kim H.J., Hawke N., Baldwin A.S. NF-κB and IKK as therapeutic targets in cancer. Cell Death Differ. 2006, 13:738-747.
11. Ko H.H., Yu S.M., Ko F.N., Teng C.M., Lin C.N. Bioactive constituents of Morus australis and Brousonetia papyrifera. J. Nat. Prod. 1997, 60:1008-1011.
12. Ko H.H., Wang J.J., Lin H.C., Wang J.P., Lin C.N. Chemistry and biological activities of constituents from Morus australis. Biochim. Biophys. Acta 1999, 1428:293-299.
13. Leber M.F., Efferth T. Molecular principles of cancer invasion and metastasis. Int. J. Oncol. 2009, 34:881-895.
14. Lee J.C., Won S.J., Chao C.L., Wu F.L., Liu H.S., Ling P., Lin C.N., Su C.L. Morusin induces apoptosis and suppresses NF-κB activity in human colorectal cancer HT-29 cells. Biochem. Biophys. Res. Commun. 2008, 372:236-242.
15. Lee H.J., Lyu D.H., Koo U., Nam K.W., Hong S.S., Kim K.O., Kim K.H., Lee D., Mar W. Protection of prenylated flavonoids from mori cortex radicis against nitric oxide-induced cell death in neuroblastoma SH-SY5Y cells. Arch. Pharm. Res. 2012, 35:163-170.
16. Määttä M., Soini Y., Liakka A., Autio-Harmainen H. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clin. Cancer Res. 2000, 6:2726-2734.
17. Masumoto A., Arao S., Otsuki M. Role of β1 integrins in adhesion and invasion of hepatocellular carcinoma cells. Hepatology 1999, 29:68-74.
18. Pedro M., Lourenco C., Cidade H., Kijjoa A., Pinto M., Nascimento M.S.J. Effects of natural prenylated flavones in the phenotypical ER (+) MCF-7 and ER (-) MDA-MB-231 human bareast cancers. Toxicol. Lett. 2006, 164:24-36.
19. Polyak K., Weinber R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
20. Sohn H.Y., Son K.H., Kwon C.S., Kwon G.S., Kang S.S. Antimicrobial and cyctotoxic activity of 18 prenyleated flavonoids isolated from medicinal plants: Morus alba L. Morus mangolica Schneider, Broussnetia papyrifera (L) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine 2004, 11:666-672.
21. Tanase A.-M., Dumitrascu T., Dima S., Grigorie R., Marchio A., Pineau P., Popescu I. Influence of hepatitis viruses on clinic-pathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma. Hepatob. Pancreat. Dis. Int. 2014, 13:162-172.
22. Tian B., Li Y., Ji X.N., Chen J., Xue Q., Ye S.L., Liu Y.K., Tang Z.Y. Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential. J. Cancer Res. Clin. Oncol. 2005, 131:80-86.
23. Torimura T., Ueno T., Kin M., Harada R., Nakamura T., Kawaguchi T., Harada M., Kumashiro R., Watanabe H., Avraham R., Sata M. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of β1 integrins. Hepatology 2001, 34:62-71.
24. Tseng T.H., Chuang S.K., Hu C.C., Chang C.F., Huang Y.C., Lin C.W., Lee Y.J. The synthesis of morusin as a potent antitumor agent. Tetrahedron 2010, 66:1335-1340.
25. Yang J.D., Roberts L.R. Epidemiology and management of hepatocellular carcinoma. Infect. Dis. Clin. North Am. 2010, 24:899-919.